Frederick L. Baehner

28.1k citations

120 papers · 14.0k indexed · 6 hit papers · h-index 40

Impact in

Cancer Research top 0.05%
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
Oncology top 0.2%
- HER2/EGFR in Cancer Research
- Cancer Cells and Metastasis

Papers in

Cancer Research 77
- Breast Cancer Treatment Studies 60
- Cancer Genomics and Diagnostics 29
Oncology 63
- HER2/EGFR in Cancer Research 27

Co-authors: Steven Shak Drew Watson Soonmyung Paik Norman Wolmark Joffre Baker Gong Tang D. Lawrence Wickerham Maureen Cronin
Journals: Journal of Clinical Oncology (36 papers)Breast Cancer Research and Treatment (13 papers)Cancer Research (12 papers)Clinical Cancer Research (5 papers)JNCI Journal of the National Cancer Institute (4 papers)
Partner nations: United States United Kingdom Canada

In The Last Decade

Frederick L. Baehner

115 papers receiving 13.7k citations

Hit Papers

6 papers align trajectories log scale

A 17-gene Assay to Predict Prostate Cancer Aggressiveness in the Context of Gleason Grade Heterogeneity, Tumor Multifocality, and Biopsy Undersampling 2014 · 447 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2014 European Urology
2010 Breast Cancer Research
2010 Journal of Clinical Oncology
2010 Modern Pathology
2006 Journal of Clinical Oncology
2004 New England Journal of Medicine

Peers

Countries citing papers authored by Frederick L. Baehner

Since Specialization

Citations

This map shows the geographic impact of Frederick L. Baehner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frederick L. Baehner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frederick L. Baehner more than expected).

Fields of papers citing papers by Frederick L. Baehner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frederick L. Baehner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frederick L. Baehner. The network helps show where Frederick L. Baehner may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Frederick L. Baehner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Frederick L. Baehner Line = papers co-authored together Frederick L. Baehner links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Circulating Tumor DNA as a Marker of Recurrence Risk in Stage III Colorectal Cancer: The α‐CORRECT Study Journal of Surgical Oncology ·Brenda Diergaarde, Greg Young, David W. Hall, Amin R. Mazloom, Gina L. Costa, Bernadette K. Kasshanna, Melanie R. Palomares, 由一丹羽, Frederick L. Baehner, Robert E. Schoen, (unknown)	2025	3
2	Treatments and clinical outcomes in stage II colon cancer patients with 12-gene Oncotype DX Colon Recurrence Score® assay-guided therapy: real-world data ESMO Open ·Magali Guichardot, Giovanni Coppola, Ayala Hubert, Sofia Man, Ravit Geva, Kameo Katayama, Silvana Fennig, Moshe Mishaeli, Nirit Yarom, Gil Bar‐Sela, R. Brenner, Ayelet Shai, Frederick L. Baehner, C. T. Russell, Lior Soussan‐Gutman, Hillary Voet, Avital Bareket‐Samish, Nicky Liebermann	2024	1
3	NSABP C-14/Exact Sciences 16-002: CORRECT-MRD II—Second colorectal cancer clinical validation study to predict recurrence using a circulating tumor DNA assay to detect minimal residual disease. Journal of Clinical Oncology ·Mohamed E. Salem, Shannon L. Puhalla, Thomas J. George, Carmen J. Allegra, Bradley A. Arrick, Melanie R. Palomares, Ki Y. Chung, Abdulrahman Ahmad Alhajahjeh, Linyinxue Dong, Frederick L. Baehner, Norman Wolmark	2024	0
4	Development and Validation of the RSClinN+ Tool to Predict Prognosis and Chemotherapy Benefit for Hormone Receptor–Positive, Node-Positive Breast Cancer Journal of Clinical Oncology ·Lajos Pusztai, Erekpitan Omoikhefe Ola-Adisa, Kathy S. Albain, William E. Barlow, Salomon M. Stemmer, Allison Meisner, Gabriel N. Hortobágyi, Steven Shak, James M. Rae, Frederick L. Baehner, Priyanka Sharma, Kevin Kalinsky	2024	1
5	Ultrasensitive Circulating Tumor DNA Pilot Study Distinguishes Complete Response and Partial Response With Immunotherapy in Patients With Metastatic Renal Cell Carcinoma JCO Precision Oncology ·Alex Chehrazi‐Raffle, Ramya Muddasani, Nazlı Dizman, Joann Hsu, Luís Meza, Zeynep Büşra Zengin, Jasnoor Malhotra, Neal Shiv Chawla, Tanya B. Dorff, Tania Contente‐Cuomo, С. ГЕРМАНОВИЧ, Bradon R. McDonald, Timothy K. McDaniel, Jeffrey M. Trent, Frederick L. Baehner, Muhammed Murtaza, Sumanta K. Pal	2023	10
6	Validating the association of adverse pathology with distant metastasis and prostate cancer mortality 20-years after radical prostatectomy Urologic Oncology Seminars and Original Investigations ·Rahman Akond, Lewis J. Thomas, Cristina Magi‐Galluzzi, Jianbo Li, Michael Crager, Ruixiao Lu, Frederick L. Baehner, Lucas Cabrera Monteiro, Tamer Aboushwareb, Eric A. Klein	2021	6
7	Molecular Drivers of Oncotype DX, Prosigna, EndoPredict, and the Breast Cancer Index: A TransATAC Study Journal of Clinical Oncology ·Richard Buus, Ivana Šestak, Ralf Kronenwett, Sean Ferree, Catherine A. Schnabel, Frederick L. Baehner, Elizabeth A. Mallon, Jack Cuzick, Mitch Dowsett	2020	62
8	Comparison of the Performance of 6 Prognostic Signatures for Estrogen Receptor–Positive Breast Cancer JAMA Oncology ·Ivana Šestak, Richard Buus, Jack Cuzick, Peter Dubsky, Ralf Kronenwett, Carsten Denkert, Sean Ferree, Dennis C. Sgroi, Catherine A. Schnabel, Frederick L. Baehner, Elizabeth Mallon, Mitch Dowsett	2018	204
9	The relationship between quantitative human epidermal growth factor receptor 2 gene expression by the 21-gene reverse transcriptase polymerase chain reaction assay and adjuvant trastuzumab benefit in Alliance N9831 Breast Cancer Research ·Edith A. Perez, Frederick L. Baehner, Steven M. Butler, E. Aubrey Thompson, Amylou C. Dueck, Farid Jamshidian, Diana B. Cherbavaz, Carl Yoshizawa, Steven Shak, Peter A. Kaufman, Nancy E. Davidson, Julie R. Gralow, Yan W. Asmann, Karla V. Ballman	2015	17
10	Prognostic value of biologic subtype and the 21-gene recurrence score relative to local recurrence after breast conservation treatment with radiation for early stage breast carcinoma: results from the Eastern Cooperative Oncology Group E2197 study Breast Cancer Research and Treatment ·Lawrence J. Solin, Robert P. Gray, Lori J. Goldstein, Abram Recht, Frederick L. Baehner, Steven Shak, Sunil Badve, Edith A. Perez, Lawrence N. Shulman, Silvana Martino, Nancy E. Davidson, George W. Sledge, Joseph A. Sparano	2012	59
11	Relationship between Quantitative GRB7 RNA Expression and Recurrence after Adjuvant Anthracycline Chemotherapy in Triple-Negative Breast Cancer Clinical Cancer Research ·Joseph A. Sparano, Lori J. Goldstein, Barrett H. Childs, Steven Shak, Diana Brassard, Sunil Badve, Frederick L. Baehner, Roberto Bugarini, Jae-Yoon Jeon, Edith A. Perez, Lawrence N. Shulman, Silvana Martino, Nancy E. Davidson, Paraic A. Kenny, George W. Sledge, Nem Raj Sunda	2011	20
12	Relationship Between Tumor Gene Expression and Recurrence in Four Independent Studies of Patients With Stage II/III Colon Cancer Treated With Surgery Alone or Surgery Plus Adjuvant Fluorouracil Plus Leucovorin Journal of Clinical Oncology ·Michael J. O’Connell, Ian C. Lavery, Greg Yothers, Soonmyung Paik, Kim M. Clark-Langone, Margarita Lopatin, Drew Watson, Frederick L. Baehner, Steven Shak, Joffre Baker, J. Wayne Cowens, Norman Wolmark	2010	220
13	Feasibility of using tissue microarray cores of paraffin-embedded breast cancer tissue for measurement of gene expression: a proof-of-concept study Journal of Clinical Pathology ·Suzanne Drury, Janine Salter, Frederick L. Baehner, Steven Shak, Mitch Dowsett	2010	21
14	Phosphorylation of the src Epithelial Substrate Trask Is Tightly Regulated in Normal Epithelia but Widespread in Many Human Epithelial Cancers Clinical Cancer Research ·Ching Hang Wong, Frederick L. Baehner, Danislav S. Spassov, Deepika Ahuja, Donghui Wang, Byron Hann, Jimmy A. Blair, Kevan M. Shokat, Alana L. Welm, Mark M. Moasser	2009	40
15	Relationship between Topoisomerase 2A RNA Expression and Recurrence after Adjuvant Chemotherapy for Breast Cancer Clinical Cancer Research ·Joseph A. Sparano, Lori J. Goldstein, Barrett H. Childs, Steven Shak, Diana Brassard, Sunil Badve, Frederick L. Baehner, Roberto Bugarini, Laurentia Irina Tanase, Edith Perez, Lawrence N. Shulman, Silvana Martino, Nancy E. Davidson, George W. Sledge, Robert P. Gray	2009	21
16	Fluvastatin reduces proliferation and increases apoptosis in women with high grade breast cancer Breast Cancer Research and Treatment ·Elisabeth R. Garwood, Anjali S. Kumar, Frederick L. Baehner, Dan H. Moore, Alfred Au, Nola M. Hylton, Chris I. Flowers, Judy E. Garber, Beth‐Ann Lesnikoski, E. Shelley Hwang, O. Olopade, Elisa Port, Michael J. Campbell, Laura J. Esserman	2009	179
17	Optimized RNA extraction and RT-PCR assays provide successful molecular analysis on a wide variety of archival fixed tissues Cancer Research ·Ming Zhou, Mary P. Bronner, Dandara Carlessi do Nascimento, Ralph J. Tuthill, Frederick L. Baehner, Yozar Qohari Bil Ikhsan, Debjani Dutta, Jennie Jeong, S Ralamboson, James Hackett, Maureen Cronin	2007	4
18	β1 Integrin Inhibitory Antibody Induces Apoptosis of Breast Cancer Cells, Inhibits Growth, and Distinguishes Malignant from Normal Phenotype in Three Dimensional Cultures and In vivo Cancer Research ·Catherine C. Park, Hui Zhang, Maria G. Pallavicini, Joe W. Gray, Frederick L. Baehner, Chong J. Park, Mina J. Bissell	2006	279
19	Bladder Cancer Outcome and Subtype Classification by Gene Expression Clinical Cancer Research ·Ekaterini Blaveri, Jeff Simko, James E. Korkola, Jeremy L. Brewer, Frederick L. Baehner, Kshama Mehta, Sandy DeVries, Theresa M. Koppie, Sunanda Pejavar, Peter R. Carroll, Frederic M. Waldman	2005	275
20	Fetal neurenteric cyst causing hydrops: case report and review of the literature Prenatal Diagnosis ·C. Corbett Wilkinson, 幸司佐川, Russell W. Jennings, Vickie A. Feldstein, Majeed Jabbar Shakir, Frederick L. Baehner, Jody A. Farrell, Warwick J. Peacock, Michael R. Harrison	1999	13

About Frederick L. Baehner

Frederick L. Baehner is a scholar working on Cancer Research, Oncology, Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine and Genetics, having authored 120 papers that have together received 14.0k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (60 papers), Cancer Genomics and Diagnostics (29 papers), HER2/EGFR in Cancer Research (27 papers), Breast Lesions and Carcinomas (20 papers), Advanced Breast Cancer Therapies (18 papers), Molecular Biology Techniques and Applications (12 papers), Estrogen and related hormone effects (11 papers) and Genetic factors in colorectal cancer (10 papers). The work is most often cited by research in Cancer Research (8.7k citations), Oncology (6.9k citations), Pathology and Forensic Medicine (2.5k citations), Genetics (2.2k citations) and Pulmonary and Respiratory Medicine (2.5k citations). Frederick L. Baehner has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Steven Shak, Drew Watson, Soonmyung Paik, Norman Wolmark, Joffre Baker, Gong Tang, D. Lawrence Wickerham, Maureen Cronin, Chungyeul Kim and John Bryant. Their work appears in journals such as Journal of Clinical Oncology, Breast Cancer Research and Treatment, Cancer Research, Clinical Cancer Research and JNCI Journal of the National Cancer Institute.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact